AQR Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-386,177
| Closed | -$425K | – | 2754 |
|
|
2024
Q2 | $425K | Sell |
386,177
-226,028
| -37% | -$249K | ﹤0.01% | 2122 |
|
|
2024
Q1 | $759K | Buy |
+612,205
| New | +$759K | ﹤0.01% | 1800 |
|
|
2023
Q2 | – | Sell |
-19,968
| Closed | -$162K | – | 2179 |
|
|
2023
Q1 | $162K | Buy |
19,968
+5,632
| +39% | +$45.6K | ﹤0.01% | 2083 |
|
|
2022
Q4 | $226K | Buy |
14,336
+3,174
| +28% | +$50K | ﹤0.01% | 2051 |
|
|
2022
Q3 | $176K | Buy |
11,162
+410
| +4% | +$6.47K | ﹤0.01% | 2060 |
|
|
2022
Q2 | $150K | Sell |
10,752
-64
| -0.6% | -$893 | ﹤0.01% | 2035 |
|
|
2022
Q1 | $186K | Sell |
10,816
-9,119
| -46% | -$157K | ﹤0.01% | 2080 |
|
|
2021
Q4 | $290K | Sell |
19,935
-39,761
| -67% | -$578K | ﹤0.01% | 1987 |
|
|
2021
Q3 | $1.08M | Buy |
59,696
+29,433
| +97% | +$530K | ﹤0.01% | 1497 |
|
|
2021
Q2 | $531K | Buy |
+30,263
| New | +$531K | ﹤0.01% | 1880 |
|
|
2017
Q4 | – | Sell |
-10,625
| Closed | -$274K | – | 2217 |
|
|
2017
Q3 | $274K | Sell |
10,625
-200
| -2% | -$5.16K | ﹤0.01% | 2107 |
|
|
2017
Q2 | $294K | Buy |
+10,825
| New | +$294K | ﹤0.01% | 2045 |
|